We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Neurodegeneration – Products

A man and a woman stand next to the Neuro-Bio and Aptamer Group logos.
Product News

Aptamer Group and Neuro-Bio Partner To Develop an Alzheimer’s Disease Diagnostic Test

Aptamer Group plc and Neuro-Bio announce success in the development of Optimer binders to enable a lateral flow test for the early diagnosis of Alzheimer’s disease.
Samsara Therapeutics logo.
Product News

Samsara Therapeutics Parkinson’s drug receives funding boost from The Michael J. Fox Foundation

Samsara Therapeutics announced that it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research to further its research into a promising Parkinson's disease drug.
Seer logo.
Product News

Seer Launches the Proteograph XT Assay Kit

Seer’s Proteograph XT pushes the boundaries of biological discovery by enabling rapid proteomics across a range of sample types and species with unprecedented resolution and scale.
The Samsara therapeutics logo
Product News

Samsara Therapeutics Unveils Promising Autophagy Drug Candidate

Samsara Therapeutics has announced the company’s autophagy-inducing candidate SAM001, the first agent of its class to enter clinical trials.
The Avacta logo.
Product News

Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Clinical Study

Avacta Group plc announces the opening of the first two clinical investigator sites for the phase 1 clinical trial of AVA6000 under its US Investigational New Drug Application.
The EpicentRx logo.
Product News

EpicentRx Receives Fast Track Designation From the U.S. FDA for Lead Asset

EpicentRx, Inc. has announced that the FDA has granted Fast Track Designation to RRx-001 for the prevention/attenuation of severe oral mucositis in chemotherapy and radiation-treated head & neck cancer patients.
Discovery of Blood-Based Biomarkers in Neurodegenerative Diseases content piece image
Whitepaper

Discovery of Blood-Based Biomarkers in Neurodegenerative Diseases

The SomaScan Assay is an ideal high throughput platform for identifying proteins that may be involved in disease pathology, as it offers a highly sensitive method of quantifying proteins in different biologic fluids such as serum, plasma, urine and cerebrospinal fluid.
ioGABAergic Neurons – iPSC-Derived Inhibitory Neurons With >95% Purity content piece image
Product
Advertisement

ioGABAergic Neurons – iPSC-Derived Inhibitory Neurons With >95% Purity

Discover ioGABAergic Neurons from bit.bio and avoid unwanted excitatory neurons obscuring inhibitory signals in your experiments. Using a simple protocol, consistently go from cryopreserved cells to mature, functional, experiment-ready hiPSC-derived GABAergic neurons with >95% purity in 12 days.
Professor Helen Walden, Dr Mehmet Gundogdu and Dr Sheelagh Frame.
Product News

Ubiquigent Collaborates With University of Glasgow on Translational Structural Biology

Ubiquigent Limited has announced it is supporting a Master’s student at the University of Glasgow to undertake a research project on USP30, a deubiquitinase implicated in neurodegenerative, renal and cardiovascular diseases.
Dr Alastair Smith, Chief Executive Officer of Avacta Group.
Product News

Avacta Announces Successful Completion of Fourth Dose Escalation in Phase 1 Clinical Study

Avacta Group plc announces that AVA6000 continues to show a very favorable safety profile in the fourth dose cohort of the ALS-6000-101 dose escalation phase 1 clinical trial.
Advertisement